Table 4.
The age-standardized incidence and mortality rates along with the ASR -based mortality-to-incidence ratio due to leukemia among males of selected countries (n = 56)
| Country | Incidence | Mortality | ASR-based MIR | ||||
|---|---|---|---|---|---|---|---|
| ASIR | Cum.Risk | ASMR | Cum.Risk | 2012 | 2020 | MIR | |
| Argentina | 7.1 | 1.61 | 4.8 | 1.33 | 0.78 | 0.68 | 0.10 |
| Australia | 13.2 | 3.1 | 4.3 | 1.75 | 0.55 | 0.32 | 0.23 |
| Austria | 9.4 | 2.15 | 4.3 | 1.58 | 0.38 | 0.46 | -0.08 |
| Belarus | 9 | 1.87 | 5 | 1.38 | 0.61 | 0.55 | 0.06 |
| Belgium | 13.6 | 2.92 | 4.7 | 1.83 | 0.45 | 0.34 | 0.11 |
| Brazil | 5.6 | 1.3 | 3.9 | 1.08 | 0.75 | 0.70 | 0.05 |
| Bulgaria | 5.9 | 0.97 | 4.9 | 1.26 | 0.65 | 0.83 | -0.18 |
| Canada | 12.2 | 2.89 | 4.3 | 1.67 | 0.38 | 0.35 | 0.03 |
| Chile | 6.6 | 1.38 | 4 | 1.12 | 0.67 | 0.61 | 0.06 |
| Colombia | 7.1 | 1.37 | 4.8 | 1.1 | 0.69 | 0.68 | 0.01 |
| Costa Rica | 7.3 | 1.34 | 4.2 | 1.11 | 0.73 | 0.57 | 0.16 |
| Croatia | 8.3 | 2.15 | 5.6 | 2.11 | 0.49 | 0.67 | -0.18 |
| Cuba | 6 | 1.13 | 3.8 | 0.93 | 0.69 | 0.63 | 0.06 |
| Cyprus | 9.5 | 2.26 | 7 | 2.7 | 0.45 | 0.74 | -0.29 |
| Czechia | 9.4 | 2.28 | 4.5 | 1.62 | 0.50 | 0.48 | 0.02 |
| Denmark | 10.1 | 2.39 | 4.4 | 1.77 | 0.45 | 0.43 | 0.02 |
| Ecuador | 7.5 | 1.5 | 5.3 | 1.26 | 0.75 | 0.71 | 0.04 |
| Egypt | 6.3 | 1.03 | 5 | 1.04 | 0.78 | 0.79 | -0.01 |
| Estonia | 11.2 | 2.35 | 5.4 | 2.12 | 0.57 | 0.48 | 0.09 |
| Finland | 8.4 | 1.82 | 3 | 1.2 | 0.39 | 0.36 | 0.03 |
| France | 11.1 | 2.69 | 4.9 | 1.89 | 0.41 | 0.44 | -0.03 |
| Germany | 9.8 | 2.26 | 4.4 | 1.79 | 0.23 | 0.45 | -0.22 |
| Iceland | 7.9 | 2.09 | 3.1 | 1.56 | 0.34 | 0.39 | -0.05 |
| Ireland | 9.6 | 2.36 | 3.6 | 1.43 | 0.33 | 0.37 | -0.04 |
| Italy | 9.2 | 1.91 | 4.4 | 1.52 | 0.28 | 0.48 | -0.20 |
| Jamaica | 5.1 | 0.96 | 3.9 | 0.79 | 0.70 | 0.76 | -0.06 |
| Japan | 6.8 | 1.24 | 3.1 | 1.03 | 0.35 | 0.45 | -0.10 |
| Kuwait | 6.6 | 1.62 | 3.9 | 1.23 | 0.63 | 0.59 | 0.04 |
| Latvia | 9.1 | 1.89 | 5.5 | 1.6 | 0.64 | 0.60 | 0.04 |
| Lithuania | 11.7 | 2.74 | 5.3 | 1.58 | 0.66 | 0.45 | 0.21 |
| Luxembourg | 9.2 | 3.37 | 4 | 1.92 | 0.45 | 0.43 | 0.02 |
| Malaysia | 7 | 0.82 | 4.9 | 0.71 | 0.80 | 0.70 | 0.10 |
| Malta | 5.5 | 1.34 | 2.3 | 0.98 | 0.41 | 0.42 | -0.01 |
| Mauritius | 7.3 | 1.62 | 4.1 | 0.93 | 0.62 | 0.56 | 0.06 |
| Netherlands | 9.5 | 2 | 4.3 | 1.85 | 0.37 | 0.45 | -0.08 |
| New Zealand | 10.2 | 2.32 | 5.2 | 1.88 | 0.47 | 0.51 | -0.04 |
| Norway | 10.4 | 2.27 | 3.9 | 1.5 | 0.40 | 0.37 | 0.03 |
| Philippines | 6.5 | 1.37 | 5 | 1.15 | 0.68 | 0.77 | -0.09 |
| Poland | 8.4 | 1.81 | 5 | 1.75 | 0.60 | 0.59 | 0.01 |
| Portugal | 8.8 | 2.11 | 4.3 | 1.53 | 0.43 | 0.49 | -0.06 |
| Qatar | 5.6 | 0.82 | 3.7 | 0.67 | 0.74 | 0.66 | 0.08 |
| Russian Federation | 7.9 | 1.44 | 4.2 | 1.02 | 0.62 | 0.53 | 0.09 |
| Serbia | 9.5 | 1.8 | 5.1 | 1.4 | 0.69 | 0.54 | 0.15 |
| Singapore | 9.9 | 1.92 | 3.9 | 1.23 | 0.42 | 0.39 | 0.03 |
| Slovakia | 10.7 | 2.4 | 5.9 | 1.67 | 0.56 | 0.55 | 0.01 |
| Slovenia | 8.9 | 2.69 | 5.5 | 2.41 | 0.48 | 0.62 | -0.14 |
| South Africa | 4.6 | 1.16 | 3.6 | 1 | 0.86 | 0.78 | 0.08 |
| Spain | 8.2 | 1.89 | 3.8 | 1.34 | 0.33 | 0.46 | -0.13 |
| Sweden | 9 | 1.89 | 3.6 | 1.37 | 0.35 | 0.40 | -0.05 |
| Switzerland | 9.2 | 2.14 | 3.7 | 1.47 | 0.31 | 0.40 | -0.09 |
| Thailand | 6.1 | 1.01 | 3.9 | 0.79 | 0.61 | 0.64 | -0.03 |
| Trinidad and Tobago | 6.2 | 0.99 | 3.9 | 0.93 | 0.75 | 0.63 | 0.12 |
| Ukraine | 7.6 | 1.21 | 4.2 | 0.78 | 0.60 | 0.55 | 0.05 |
| United Kingdom | 10.6 | 2.61 | 3.7 | 1.51 | 0.44 | 0.35 | 0.09 |
| United States of America | 13.4 | 3.15 | 4.1 | 1.6 | 0.56 | 0.30 | 0.26 |
| Uruguay | 7.8 | 1.88 | 4.4 | 1.61 | 0.74 | 0.56 | 0.18 |
ASIR age-standardized incidence rate, Cum cumulative, ASMR age-standardized mortality rate, MIR mortality-to-incidence ratio